Barclays analyst Peter Lawson lowered the price target on Arcus Biosciences (NYSE: RCUS) to $25.00 ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE